1. HER2-enriched subtype and pathological complete response in HER2-positive breast cancer: A systematic review and meta-analysis. (March 2020) Authors: Schettini, Francesco; Pascual, Tomás; Conte, Benedetta; Chic, Nuria; Brasó-Maristany, Fara; Galván, Patricia; Martínez, Olga; Adamo, Barbara; Vidal, Maria; Muñoz, Montserrat; Fernández-Martinez, Aranzazu; Rognoni, Carla; Griguolo, Gaia; Guarneri, Valentina; Conte, Pier Franco; Locci, Mariavittori... Journal: Cancer treatment reviews Issue: Volume 84(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Randomized Phase III Trial Evaluating Spartalizumab Plus Dabrafenib and Trametinib for BRAF V600–Mutant Unresectable or Metastatic Melanoma. Issue 13 (1st May 2022) Authors: Dummer, Reinhard; Long, Georgina V.; Robert, Caroline; Tawbi, Hussein A.; Flaherty, Keith T.; Ascierto, Paolo A.; Nathan, Paul D.; Rutkowski, Piotr; Leonov, Oleg; Dutriaux, Caroline; Mandalà, Mario; Lorigan, Paul; Ferrucci, Pier Francesco; Grob, Jean Jacques; Meyer, Nicolas; Gogas, Helen; Stroyak... Journal: Journal of clinical oncology Issue: Volume 40:Issue 13(2022) Page Start: 1428 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗